| Title |
Anti-obesity effects of Yerba Mate (Ilex Paraguariensis): a randomized, double-blind, placebo-controlled clinical trial
|
|---|---|
| Published in |
BMC Complementary Medicine and Therapies, September 2015
|
| DOI | 10.1186/s12906-015-0859-1 |
| Pubmed ID | |
| Authors |
Sun-Young Kim, Mi-Ra Oh, Min-Gul Kim, Han-Jeoung Chae, Soo-Wan Chae |
| Abstract |
Obesity is a major health problem. A food field research that has recently aroused considerable interest is the potential of natural products to counteract obesity. Yerba Mate may be helpful in reducing body weight and fat. The aim of this study was to investigate the efficacy and safety of Yerba Mate supplementation in Korean subjects with obesity. A randomized, double-blind, placebo-controlled trial was conducted. Subjects with obesity (body mass index (BMI) ≥ 25 but < 35 kg/m(2) and waist-hip ratio (WHR) ≥ 0.90 for men and ≥ 0.85 for women) were given oral supplements of Yerba Mate capsules (n = 15) or placebos (n = 15) for 12 weeks. Subjects take three capsules per each meal, total three times in a day (3 g/day). Measured outcomes were efficacy (abdominal fat distribution, anthropometric parameters and blood lipid profiles) and safety (adverse events, laboratory test results and vital signs). During 12 weeks of Yerba Mate supplementation, decreases in body fat mass (P = 0.036) and percent body fat (P = 0.030) compared to the placebo group were statistically significant. WHR was significantly decreased (P = 0.004) in the Yerba Mate group compared to the placebo group. No clinically significant changes in any safety parameters were observed. Yerba Mate supplementation decreased body fat mass, percent body fat and WHR. Yerba Mate was a potent anti-obesity reagent that did not produce significant adverse effects. These results suggested that Yerba Mate supplementation may be effective for treating obese individuals. ClinicalTrials.gov: ( NCT01778257 ). |
X Demographics
The data shown below were collected from the profiles of 24 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Argentina | 3 | 13% |
| Spain | 2 | 8% |
| United States | 2 | 8% |
| Saudi Arabia | 1 | 4% |
| Mexico | 1 | 4% |
| Venezuela, Bolivarian Republic of | 1 | 4% |
| Australia | 1 | 4% |
| Unknown | 13 | 54% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 18 | 75% |
| Practitioners (doctors, other healthcare professionals) | 3 | 13% |
| Scientists | 3 | 13% |
Mendeley readers
The data shown below were compiled from readership statistics for 197 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Uruguay | 1 | <1% |
| Australia | 1 | <1% |
| Brazil | 1 | <1% |
| Unknown | 194 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 30 | 15% |
| Student > Master | 23 | 12% |
| Researcher | 17 | 9% |
| Student > Ph. D. Student | 15 | 8% |
| Student > Doctoral Student | 11 | 6% |
| Other | 29 | 15% |
| Unknown | 72 | 37% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 28 | 14% |
| Nursing and Health Professions | 21 | 11% |
| Agricultural and Biological Sciences | 18 | 9% |
| Biochemistry, Genetics and Molecular Biology | 13 | 7% |
| Pharmacology, Toxicology and Pharmaceutical Science | 10 | 5% |
| Other | 24 | 12% |
| Unknown | 83 | 42% |
Attention Score in Context
This research output has an Altmetric Attention Score of 232. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 March 2024.
All research outputs
#165,238
of 25,546,214 outputs
Outputs from BMC Complementary Medicine and Therapies
#30
of 3,969 outputs
Outputs of similar age
#2,089
of 286,623 outputs
Outputs of similar age from BMC Complementary Medicine and Therapies
#1
of 89 outputs
Altmetric has tracked 25,546,214 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,969 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 286,623 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 89 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.